Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: Long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Robert B. Nussenblatt, Darby J.S. Thompson, Zhuqing Li, Jan S. Peterson, Randy R. Robinson, Richard S. Shames, Sudha Nagarajan, Meina Tao Tang, Michelle Mailman, Gisela Velez, Chandra Roy, Grace A. Levy-Clarke, Eric B. Suhler, Ali Djalilian, Hatice Nida Sen, Shadi Al-Khatib, Roxana Ursea, Sunil Srivastava, Allison Bamji, Susan MellowPushpa Sran, Thomas A. Waldmann, Ronald R. Buggage

Research output: Contribution to journal › Article › peer-review

109 Scopus citations

Fingerprint

Dive into the research topics of 'Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: Long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration'. Together they form a unique fingerprint.

Medicine & Life Sciences